Nuclear Medicine Imaging Techniques in Glioblastomas

Area of Science:

• Neuro-oncology
• Nuclear Medicine Imaging
• Central Nervous System (CNS) Tumors

Background:

• Glioblastoma is the most common and aggressive primary malignant grade 4 CNS tumor.
• It has a poor prognosis, with survival rates around 8 months, especially upon recurrence.
• Standard treatment involves surgery followed by chemoradiotherapy.

Purpose of the Study:

• To review recent advancements in nuclear medicine techniques for glioblastoma.
• To highlight the critical role of imaging in diagnosis, treatment planning, and monitoring.
• To provide a summary guide for nuclear medicine applications in glioblastoma.

Main Methods:

• Review of current literature and studies on nuclear medicine in glioblastoma.
• Focus on Positron Emission Tomography (PET) scan applications.
• Discussion of emerging nuclear medicine techniques and biomarkers.

Main Results:

• PET scans are essential for tumor localization, pre-surgical planning, and assessing treatment response.
• Nuclear medicine aids significantly in detecting glioblastoma recurrence.
• Recent advances improve the understanding and application of nuclear medicine in glioblastoma management.

Conclusions:

• Nuclear medicine plays an indispensable, evolving role in the multidisciplinary management of glioblastoma.
• Continued research is crucial for developing novel nuclear medicine strategies against glioblastoma.
• Enhanced imaging capabilities improve patient outcomes through precise diagnosis and monitoring.